Point-of-care testing of blood glucose in the neonatal unit using the AVL Omni 9 analyser.
Ann Clin Biochem
; 39(Pt 5): 509-12, 2002 Sep.
Article
em En
| MEDLINE
| ID: mdl-12227858
ABSTRACT
BACKGROUND:
Blood glucose measurements in newborns at risk of hypoglycaemia are an essential part of their medical management. Blood glucose measurements obtained by point-of-care testing using an AVL Omni 9 blood gas and metabolite analyser were compared with those obtained in the central laboratory using a Dade Dimension RXL analyser.METHODS:
Blood glucose was measured at the point of care by nursing staff using an AVL Omni 9 blood gas and metabolite analyser and compared to results obtained in the central laboratory using a DADE Dimension RXL analyser. In total, 123 samples were taken from 114 babies admitted to the neonatal unit.RESULTS:
The limits of agreement between the AVL Omni 9 and the central laboratory were 0.0 +/- 0.6 mmol/L for glucose values between 0.5 and 13 mmol/L. Regression analysis showed AVL Omni 9 glucose = 0.977 x plasma glucose+0.14. There was also a good correlation (r = 0.92) between the AVL Omni 9 and the DADE Dimension RXL analyser for glucose values < 3 mmol/L. The limits of agreement for the AVL Omni 9 when compared with the DADE Dimension RXL analyser were -0.1 +/- 0.5 mmol/L.DISCUSSION:
Point-of-care testing of blood glucose using the AVL Omni 9 blood gas and metabolite analyser is a reliable means of measuring blood glucose and has the advantage of providing a fast result using small volumes of blood.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Glicemia
/
Recém-Nascido
/
Técnicas Biossensoriais
/
Sistemas Automatizados de Assistência Junto ao Leito
Tipo de estudo:
Diagnostic_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2002
Tipo de documento:
Article